Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women

LANCET

ELSEVIER SCIENCE INC

1. NIAID NIH HHS [U01 AI095031, P30 AI050410] Funding Source: Medline